Home Blood Pressure Telemonitoring + Community Health Worker Support for High Blood Pressure
(LINKED-BP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those already on antihypertensive medication. If you are on such medication, you would not be eligible to participate.
What data supports the effectiveness of the LINKED-BP Program treatment for high blood pressure?
Research shows that home blood pressure monitoring, especially when combined with support from community health workers, can significantly reduce blood pressure. Studies have found that people who monitor their blood pressure at home and receive guidance from community workers or pharmacists have better blood pressure control compared to those who receive usual care.12345
Is the Home Blood Pressure Telemonitoring + Community Health Worker Support program safe for humans?
What makes the LINKED-BP Program treatment unique for high blood pressure?
The LINKED-BP Program is unique because it combines home blood pressure monitoring with a mobile health app and support from community health workers, who provide personalized guidance and education. This approach not only focuses on medical management but also addresses social factors that affect health, making it particularly effective for underserved communities.23578
What is the purpose of this trial?
The LINKED-BP Program is a patient-centered, multi-level intervention linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo) that links with all Bluetooth-enabled validated blood pressure (BP) devices, support from community health workers (CHWs), and BP measurement training at community health centers serving high-risk adults to prevent stage 2 hypertension (BP ≥ 140/90 mm Hg). The LINKED-BP Program study will recruit a total of 600 adults (30 from each practice) with elevated BP (120-129/\<80 mm Hg) or untreated stage 1 hypertension (130-139/80-89 mm Hg) across 20 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors (HBPM) and will be managed by the patients' primary care clinicians as usual; and (2) the LINKED-BP Program or "intervention arm," which will include training of patients on HBPM, Sphygmo BP telemonitoring app, and CHW visits for education and counseling on lifestyle modification. The intervention period for each study participant is 12 months.
Research Team
Yvonne Commodore-Mensah, PhD, MHS, RN
Principal Investigator
JHU School Of Nursing
Eligibility Criteria
Adults over 18 with elevated blood pressure or untreated stage 1 hypertension, who are non-Hispanic white, African-American, or Hispanic and receive care at participating centers. Excluded are those on blood pressure meds, with end-stage renal disease, serious conditions like cancer, cognitive impairments, or an upper arm circumference >50 cm.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive training on home blood pressure monitoring, use of the Sphygmo telemonitoring app, and support from community health workers for lifestyle modification
Follow-up
Participants are monitored for changes in blood pressure and overall health outcomes
Treatment Details
Interventions
- LINKED-BP Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
American Heart Association
Collaborator